142 related articles for article (PubMed ID: 18536687)
21. Identification of potential HIV-1 targets of minocycline.
Jenwitheesuk E; Samudrala R
Bioinformatics; 2007 Oct; 23(20):2797-9. PubMed ID: 17804437
[TBL] [Abstract][Full Text] [Related]
22. An integrative approach for predicting interactions of protein regions.
Schelhorn SE; Lengauer T; Albrecht M
Bioinformatics; 2008 Aug; 24(16):i35-41. PubMed ID: 18689837
[TBL] [Abstract][Full Text] [Related]
23. Genome scale enzyme-metabolite and drug-target interaction predictions using the signature molecular descriptor.
Faulon JL; Misra M; Martin S; Sale K; Sapra R
Bioinformatics; 2008 Jan; 24(2):225-33. PubMed ID: 18037612
[TBL] [Abstract][Full Text] [Related]
24. A Bayesian regression approach to the prediction of MHC-II binding affinity.
Zhang W; Liu J; Niu YQ; Wang L; Hu X
Comput Methods Programs Biomed; 2008 Oct; 92(1):1-7. PubMed ID: 18562039
[TBL] [Abstract][Full Text] [Related]
25. A look inside HIV resistance through retroviral protease interaction maps.
Kontijevskis A; Prusis P; Petrovska R; Yahorava S; Mutulis F; Mutule I; Komorowski J; Wikberg JE
PLoS Comput Biol; 2007 Mar; 3(3):e48. PubMed ID: 17352531
[TBL] [Abstract][Full Text] [Related]
26. Protease substrate site predictors derived from machine learning on multilevel substrate phage display data.
Chen CT; Yang EW; Hsu HJ; Sun YK; Hsu WL; Yang AS
Bioinformatics; 2008 Dec; 24(23):2691-7. PubMed ID: 18974075
[TBL] [Abstract][Full Text] [Related]
27. ProtIdent: a web server for identifying proteases and their types by fusing functional domain and sequential evolution information.
Chou KC; Shen HB
Biochem Biophys Res Commun; 2008 Nov; 376(2):321-5. PubMed ID: 18774775
[TBL] [Abstract][Full Text] [Related]
28. A quantitative analysis of kinase inhibitor selectivity.
Karaman MW; Herrgard S; Treiber DK; Gallant P; Atteridge CE; Campbell BT; Chan KW; Ciceri P; Davis MI; Edeen PT; Faraoni R; Floyd M; Hunt JP; Lockhart DJ; Milanov ZV; Morrison MJ; Pallares G; Patel HK; Pritchard S; Wodicka LM; Zarrinkar PP
Nat Biotechnol; 2008 Jan; 26(1):127-32. PubMed ID: 18183025
[TBL] [Abstract][Full Text] [Related]
29. Finding time for allosteric interactions.
Wainer IW
Nat Biotechnol; 2004 Nov; 22(11):1376-7. PubMed ID: 15529160
[No Abstract] [Full Text] [Related]
30. The next chapter in reverse vaccinology.
Musser JM
Nat Biotechnol; 2006 Feb; 24(2):157-8. PubMed ID: 16465156
[No Abstract] [Full Text] [Related]
31. [From systematic analysis of protein interaction networks to chemical-biology].
Natsume T
Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1649-54. PubMed ID: 18051394
[No Abstract] [Full Text] [Related]
32. Exploring sequence space: profile analysis and protein-ligand docking to screen omega-aminotransferases with expanded substrate specificity.
Seo JH; Park HY; Kim J; Lee BS; Kim BG
Biotechnol J; 2008 May; 3(5):676-86. PubMed ID: 18398873
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive and reliable phosphorylation site mapping of individual phosphoproteins by combination of multiple stage mass spectrometric analysis with a target-decoy database search.
Han G; Ye M; Jiang X; Chen R; Ren J; Xue Y; Wang F; Song C; Yao X; Zou H
Anal Chem; 2009 Jul; 81(14):5794-805. PubMed ID: 19522514
[TBL] [Abstract][Full Text] [Related]
34. Intraproteomic networks: new forays into predicting interaction partners.
Aravind L; Iyer LM
Genome Res; 2002 Aug; 12(8):1156-8. PubMed ID: 12176922
[No Abstract] [Full Text] [Related]
35. An informatic framework for decoding protein complexes by top-down mass spectrometry.
Skinner OS; Havugimana PC; Haverland NA; Fornelli L; Early BP; Greer JB; Fellers RT; Durbin KR; Do Vale LH; Melani RD; Seckler HS; Nelp MT; Belov ME; Horning SR; Makarov AA; LeDuc RD; Bandarian V; Compton PD; Kelleher NL
Nat Methods; 2016 Mar; 13(3):237-40. PubMed ID: 26780093
[TBL] [Abstract][Full Text] [Related]
36. The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network.
Zhu M; Gao L; Li X; Liu Z; Xu C; Yan Y; Walker E; Jiang W; Su B; Chen X; Lin H
J Drug Target; 2009 Aug; 17(7):524-32. PubMed ID: 19530902
[TBL] [Abstract][Full Text] [Related]
37. [Human proteome].
Natsume T
Tanpakushitsu Kakusan Koso; 2005 Dec; 50(16 Suppl):2065-71. PubMed ID: 16411431
[No Abstract] [Full Text] [Related]
38. Active site profiling to identify protein functional sites in sequences and structures using the Deacon Active Site Profiler (DASP).
Fetrow JS
Curr Protoc Bioinformatics; 2006 Jul; Chapter 8():8.10.1-8.10.16. PubMed ID: 18428769
[TBL] [Abstract][Full Text] [Related]
39. Deciphering protein-protein interactions. Part I. Experimental techniques and databases.
Shoemaker BA; Panchenko AR
PLoS Comput Biol; 2007 Mar; 3(3):e42. PubMed ID: 17397251
[No Abstract] [Full Text] [Related]
40. Discover protein sequence signatures from protein-protein interaction data.
Fang J; Haasl RJ; Dong Y; Lushington GH
BMC Bioinformatics; 2005 Nov; 6():277. PubMed ID: 16305745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
